NOMAD HEALTH TECHNOLOGIES LTD

Company Registration Number:
10172968 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2023

Period of accounts

Start date: 01 April 2022

End date: 31 March 2023

NOMAD HEALTH TECHNOLOGIES LTD

Contents of the Financial Statements

for the Period Ended 31 March 2023

Balance sheet
Notes

NOMAD HEALTH TECHNOLOGIES LTD

Balance sheet

As at 31 March 2023


Notes

2023

2022


£

£
Fixed assets
Intangible assets: 3 1,424 1,871
Tangible assets: 4 167,009 161,408
Total fixed assets: 168,433 163,279
Current assets
Stocks: 87,513 104,288
Debtors:   289,276 303,911
Cash at bank and in hand: 19,610 62,162
Total current assets: 396,399 470,361
Creditors: amounts falling due within one year:   (441,708) (404,698)
Net current assets (liabilities): (45,309) 65,663
Total assets less current liabilities: 123,124 228,942
Creditors: amounts falling due after more than one year:   (65,000) (362,178)
Total net assets (liabilities): 58,124 (133,236)
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 58,123 (133,237)
Shareholders funds: 58,124 (133,236)

The notes form part of these financial statements

NOMAD HEALTH TECHNOLOGIES LTD

Balance sheet statements

For the year ending 31 March 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 15 February 2024
and signed on behalf of the board by:

Name: Andrew Lewis
Status: Director

The notes form part of these financial statements

NOMAD HEALTH TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover comprises the invoice value of goods supplied by the company, exclusive of trade discounts and value added tax.

Tangible fixed assets and depreciation policy

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringingthe asset to the location and condition necessary for it to be capable of operating in the manner intended by management.Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.Depreciation is provided on the following basis:Long leasehold property - 5 years straight lineOffice equipment - 25% - 33% straight line per annumFixtures and fittings - 15% Straight line per annumComputer equipment - 20% Straight line per annumThe assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Intangible fixed assets and amortisation policy

PatentsPatents are valued at cost less accumulated amortisation.GoodwillGoodwill represents the difference between amounts paid on the cost of a business combination and the acquirer’s interest in the fair value of its identifiable assets and liabilities of the acquiree at the date of acquisition. Subsequent to initial recognition, goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is amortised on a straight line basis to the Statement of comprehensive income over its useful economic life.Other intangible assetsIntangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

NOMAD HEALTH TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

2. Employees

2023 2022
Average number of employees during the period 61 61

NOMAD HEALTH TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

3. Intangible Assets

Total
Cost £
At 01 April 2022 4,481
Additions 0
Disposals 0
At 31 March 2023 4,481
Amortisation
At 01 April 2022 2,610
Charge for year 447
At 31 March 2023 3,057
Net book value
At 31 March 2023 1,424
At 31 March 2022 1,871

NOMAD HEALTH TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

4. Tangible Assets

Total
Cost £
At 01 April 2022 639,980
Additions 100,690
At 31 March 2023 740,670
Depreciation
At 01 April 2022 478,572
Charge for year 95,089
At 31 March 2023 573,661
Net book value
At 31 March 2023 167,009
At 31 March 2022 161,408

NOMAD HEALTH TECHNOLOGIES LTD

Notes to the Financial Statements

for the Period Ended 31 March 2023

5. Post balance sheet events

There have been no significant events affecting the company since the financial year-end.